Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis.
Jayawardana, S; WEERASURIYA, CK; Pelzer, PT; SEELEY, J; Harris, RC; Tameris, M; Tait, D; WHITE, RG; Asaria, M;
2022
npj Vaccines, (2022).7 1 10.1038/s41541-022-00554-1.
The Natural History of Untreated Pulmonary Tuberculosis in Adults: A Systematic Review and Meta-Analysis.
Sossen, B; RICHARDS, A; Heinsohn, T; Frascella, B; Balzarini, F; Oradini-Alacreu, A; Odone, A; Rogozińska, E; Häcker, B; Cobelens, F; Kranzer, K; HOUBEN, RM G J; Esmail, H;
2022
medRxiv (2022). 10.1101/2022.08.30.22279374.
Thoracic ultrasound for TB diagnosis in adults and children.
Fentress, M; Henwood, PC; Maharaj, P; Mitha, M; Khan, D; Jackpersad, R; Pitcher, R; Redfern, A; Lopez Varela, E; Van der Zalm, MM; Wong, EB; Palmer, M; GRANT, AD;
2022
Public Health Action, (2022).12 1 10.5588/pha.21.0072.
The Correlated Beta Dose Optimisation Approach: Optimal Vaccine Dosing Using Mathematical Modelling and Adaptive Trial Design.
Benest, J; Rhodes, S; Evans, TG; WHITE, RG;
2022
Vaccines, (2022).10 11 10.3390/vaccines10111838.
Tuberculosis prevalence: beyond the tip of the iceberg.
HOUBEN, RM G J; Esmail, H; Cobelens, F; Williams, CM L; Coussens, AK;
2022
The Lancet Respiratory medicine, (2022).10 6 10.1016/S2213-2600(22)00184-9.
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial.
Scriba, TJ; Fiore-Gartland, A; Penn-Nicholson, A; Mulenga, H; Kimbung Mbandi, S; Borate, B; Mendelsohn, SC; Hadley, K; Hikuam, C; Kaskar, M; Musvosvi, M; Bilek, N; Self, S; SUMNER, T; WHITE, RG; Erasmus, M; Jaxa, L; Raphela, R; Innes, C; Brumskine, W; Hiemstra, A; Malherbe, ST; Hassan-Moosa, R; Tameris, M; Walzl, G; ... CORTIS-01 Study Team,
2021
The Lancet. Infectious diseases, (2021).21 3 10.1016/S1473-3099(20)30914-2.
Population pharmacokinetics and pharmacodynamics of investigational regimens' drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial.
NYANG'WA, B-T; Kloprogge, F; MOORE, DA J; Bustinduy, A; Motta, I; Berry, C; Davies, GR;
2021
BMJ open, (2021).11 9 10.1136/bmjopen-2020-047185.
Optimising Vaccine Dose in Inoculation against SARS-CoV-2, a Multi-Factor Optimisation Modelling Study to Maximise Vaccine Safety and Efficacy.
BENEST, J; RHODES, S; QUAIFE, M; Evans, TG; WHITE, RG;
2021
Vaccines, (2021).9 2 10.3390/vaccines9020078.
Feasibility of an mobile application as a tool for multidrug-resistant tuberculosis contact monitoring in Peru.
Allen, R; Calderón, M; MOORE, DA J; GASKELL, KM; Curisinche-Rojas, M; López, S;
2021
Revista peruana de medicina experimental y salud publica, (2021).38 2 10.17843/rpmesp.2021.382.6236.
Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis.
Cattamanchi, A; Reza, TF; Nalugwa, T; Adams, K; Nantale, M; Oyuku, D; Nabwire, S; Babirye, D; Turyahabwe, S; Tucker, A; Sohn, H; Ferguson, O; Thompson, R; Shete, PB; Handley, MA; Ackerman, S; Joloba, M; MOORE, DA J; Davis, JL; Dowdy, DW; FIELDING, K; Katamba, A;
2021
The New England journal of medicine, (2021).385 26 10.1056/NEJMoa2105470.